Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Sci Rep ; 12(1): 9998, 2022 06 15.
Article in English | MEDLINE | ID: mdl-35705722

ABSTRACT

Bee pollen is recommended as dietary supplement due to immunostimulating functions including antioxidant, anti-inflammatory and anti-carcinogenic properties. Nevertheless, the effectiveness of such properties is still not well understood. As diet can be associated with animal performance, microbiota modulation and potentially factor for cancer, this study aimed to analyze if bee pollen could influence growth, gut microbial and skin cutaneous melanoma development in zebrafish. Control diets based on commercial flakes and Artemia were compared with the same diet supplemented with bee pollen. Fish weight gain, increased length, intestinal bacteria metagenomics analysis, serum amyloid A gene expression and cutaneous melanoma transplantation assays were performed. Bee pollen affected microbiota composition and melanoma development. Differential abundance revealed higher abundance in the control group for Aeromonadaceae family, Aeromonas and Pseudomonas genus, A. sobria, A. schubertii, A. jandaei and P. alcaligenes species compared with pollen diet group. Pollen group presented higher abundance for Chromobacterium genus and for Gemmobacter aquaticus, Flavobacterium succinicans and Bifidobacterium breve compared with control group. Unexpectedly, fish fed with bee pollen showed higher tumor growth rate and larger tumor size than control group. This is the first study to report intestinal microbial changes and no protective cancer properties after bee pollen administration.


Subject(s)
Gastrointestinal Microbiome , Melanoma , Skin Neoplasms , Animals , Bees , Diet , Melanoma/etiology , Pollen , Skin Neoplasms/etiology , Zebrafish , Melanoma, Cutaneous Malignant
2.
J Exp Clin Cancer Res ; 38(1): 405, 2019 Sep 13.
Article in English | MEDLINE | ID: mdl-31519199

ABSTRACT

BACKGROUND: Skin cutaneous melanoma (SKCM) is the most lethal form of skin cancer and while incidence rates are declining for most cancers, they have been steadily rising for SKCM. Serine protease inhibitor, kunitz-type, 1 (SPINT1) is a type II transmembrane serine protease inhibitor that has been shown to be involved in the development of several types of cancer, such as squamous cell carcinoma and colorectal cancer. METHODS: We used the unique advantages of the zebrafish to model the impact of Spint1a deficiency in early transformation, progression and metastatic invasion of SKCM together with in silico analysis of the occurrence and relevance of SPINT1 genetic alterations of the SKCM TCGA cohort. RESULTS: We report here a high prevalence of SPINT1 genetic alterations in SKCM patients and their association with altered tumor immune microenvironment and poor patient survival. The zebrafish model reveals that Spint1a deficiency facilitates oncogenic transformation, regulates the tumor immune microenvironment crosstalk, accelerates the onset of SKCM and promotes metastatic invasion. Notably, Spint1a deficiency is required at both cell autonomous and non-autonomous levels to enhance invasiveness of SKCM. CONCLUSIONS: These results reveal a novel therapeutic target for SKCM.


Subject(s)
Cell Communication , Melanoma/etiology , Melanoma/metabolism , Proteinase Inhibitory Proteins, Secretory/genetics , Skin Neoplasms/etiology , Skin Neoplasms/metabolism , Tumor Microenvironment/immunology , Allografts , Animals , Biomarkers , Biopsy , Disease Models, Animal , Disease Progression , Gene Expression , Gene Knockout Techniques , Heterografts , Humans , Immunomodulation , Immunophenotyping , Macrophages/immunology , Macrophages/metabolism , Melanoma/mortality , Melanoma/pathology , Prognosis , Proteinase Inhibitory Proteins, Secretory/metabolism , Skin Neoplasms/mortality , Skin Neoplasms/pathology , Zebrafish , Melanoma, Cutaneous Malignant
3.
Fish Shellfish Immunol ; 90: 215-222, 2019 Jul.
Article in English | MEDLINE | ID: mdl-31039438

ABSTRACT

The zebrafish has unique advantages for understanding the evolution of vertebrate immunity and to model human diseases. In this review, we will firstly give an overview of the current knowledge on vertebrate innate immune receptors with special emphasis on the inflammasome and then summarize the main contribution of the zebrafish model to this field, including to the identification of novel inflammasome components and to the mechanisms involved in its activation, assembly and clearance of intracellular bacteria.


Subject(s)
Biological Evolution , Fish Proteins/genetics , Immunity, Innate , Receptors, Immunologic/genetics , Zebrafish/immunology , Animals , Disease Models, Animal , Evolution, Molecular , Fish Proteins/metabolism , Immunity, Innate/genetics , Models, Animal , Receptors, Immunologic/metabolism , Zebrafish/genetics , Zebrafish/metabolism
4.
Int J Cancer ; 142(3): 584-596, 2018 02 01.
Article in English | MEDLINE | ID: mdl-28949016

ABSTRACT

The protein bcl-xL is able to enhance the secretion of the proinflammatory chemokine interleukin 8 (CXCL8) in human melanoma lines. In this study, we investigate whether the bcl-xL/CXCL8 axis is important for promoting melanoma angiogenesis and aggressiveness in vivo, using angiogenesis and xenotransplantation assays in zebrafish embryos. When injected into wild-type embryos, bcl-xL-overexpressing melanoma cells showed enhanced dissemination and angiogenic activity compared with control cells. Human CXCL8 protein elicited a strong proangiogenic activity in zebrafish embryos and zebrafish Cxcr2 receptor was identified as the mediator of CXCL8 proangiogenic activity using a morpholino-mediated gene knockdown. However, human CXCL8 failed to induce neutrophil recruitment in contrast to its zebrafish homolog. Interestingly, the greater aggressiveness of bcl-xL-overexpressing melanoma cells was mediated by an autocrine effect of CXCL8 on its CXCR2 receptor, as confirmed by an shRNA approach. Finally, correlation studies of gene expression and survival analyses using microarray and RNA-seq public databases of human melanoma biopsies revealed that bcl-xL expression significantly correlated with the expression of CXCL8 and other markers of melanoma progression. More importantly, a high level of co-expression of bcl-xL and CXCL8 was associated with poor prognosis in melanoma patients. In conclusion, these data demonstrate the existence of an autocrine CXCL8/CXCR2 signaling pathway in the bcl-xL-induced melanoma aggressiveness, encouraging the development of novel therapeutic approaches for high bcl-xL-expressing melanoma.


Subject(s)
Interleukin-8/metabolism , Melanoma/blood supply , bcl-X Protein/metabolism , Animals , Animals, Genetically Modified , Cell Line, Tumor , Heterografts , Humans , Interleukin-8/biosynthesis , Interleukin-8/genetics , Interleukin-8/pharmacology , Melanoma/genetics , Melanoma/metabolism , Neovascularization, Pathologic/metabolism , Recombinant Proteins/pharmacology , Tumor Microenvironment , Zebrafish , bcl-X Protein/biosynthesis , bcl-X Protein/genetics
SELECTION OF CITATIONS
SEARCH DETAIL
...